1
Clinical Trials associated with Somatropin biosimilar(Teva Pharmaceutical Industries Ltd.)A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study, to Assess Tolerability, Safety, Pharmacokinetic and Pharmacodynamic Profiles of hGH-ViaDerm™ System in Adult Subjects With Growth Hormone Deficiency
This study aims to examine the safety, tolerability and pharmacokinetics of transdermal delivery of human Growth Hormone (hGH or somatropin) using the ViaDerm device in adult patients with Growth Hormone Deficiency Syndrome.
100 Clinical Results associated with Somatropin biosimilar(Teva Pharmaceutical Industries Ltd.)
100 Translational Medicine associated with Somatropin biosimilar(Teva Pharmaceutical Industries Ltd.)
100 Patents (Medical) associated with Somatropin biosimilar(Teva Pharmaceutical Industries Ltd.)
100 Deals associated with Somatropin biosimilar(Teva Pharmaceutical Industries Ltd.)